News Chart MegaPro Biomedical Co., Ltd

Equities

End-of-day quote Taipei Exchange Other stock markets 23:00:00 13/06/2024 BST			5-day change	1st Jan Change
23 ^TWD	+1.77%		+2.22%	-5.54%

2022	Megapro Biomedical Co., Ltd Successfully Completes the Biological Evaluations of Iop as Vaccine Adjuvant T Cell Mediated Immunity Is Substantially Enhanced, Improving the Efficacy of Vaccines	CI
2022	Megapro Biomedical Co., Ltd, China Chemical & Pharmaceutical Co., Ltd. and Wellbridge Biotech Ltd. Jointly Establishes an Inhalation Dosage Form Company	CI

d898f352a7.CY1s_x0iBNWmwOujQSgM_3WLipKoOC6zF6J7UIe5nhI.b_gmu3NbMpjMj4jgEUFIyCXq5-H8f1_Rb8RMP-T1r31ayCqNbhdC5_yhmA~02f5ce09c6f09ef4d294417d2d4c796e